Bicalutamide treatment for locally advanced prostate cancer

Hospital Medicine

Volumn 61, Issue 9, 2000, Pages 660-663

  Anderson, John ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANILIDE; ANTIANDROGEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; BICALUTAMIDE;

BONE DENSITY; DRUG EFFECT; HUMAN; MALE; PROSTATE TUMOR; QUALITY OF LIFE; REVIEW;

ANDROGEN ANTAGONISTS; ANILIDES; ANTINEOPLASTIC AGENTS, HORMONAL; BONE DENSITY; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY OF LIFE;

EID: 0034269076     PISSN: 14623935     EISSN: None     Source Type: Journal    
DOI: 10.12968/hosp.2000.61.9.1426     Document Type: Article

References (15)

1. Buchholz N P. Mattarelli G (1994) Hot flushes after orchidectomy in treatment of prostate cancer-a serious side effect. Z Gerontol 27: 334 6
2. Cooper C (1997) The crippling consequences of fractures and their impact on quality of life. Am Mal 103(2A): 12-9
3. Daniell HW, Dunn SR, Fcrguson DW, L.onias G. Niazi Z. Strattc PT (2000) Progressive ostcoporosis during androgcn deprivation therapy for prostate cancer. J Vml 163: 181-6
4. Iversen P (1999) Quality of life issues relating to endocrine treatment options. Eur L nil 36(suppl 2): 20-6
5. Kersen P, Tyrrell CJ. Kaisary AV ct al (2000) Bicalutamide ('Casodex) 150 nig monotherapy compared with castration in patients with non-metastatic locally advanced prostate cancer: 6.3 years' follow-up. J Uivm press)
6. Kirhv R (I99X) Treatment options for early prostate cancer. Urology 52: 948-62
7. Kirhy RS. Chodak C,W, Watson A. Newlin DWW (1998) Prostate cancer and sexual function. Prusl Cancel' frost Dix I: 179-X4
8. Kolvenbag CiJC'M, Nash A (1999) Bicalutamidc dosages used in the treatment of prostate cancer. Prostate 39: 47-53
9. Mazur D.I. Hickman DH (1993) Patient preferences. Survival vs quality-of-lifc considerations. J den Intern Med 8: 374-7
10. Roach M (1997) N'eoadjuvant therapy prior to radiotherapy for clinically localized prostate cancer, Eur Unit 32(suppl 3): 48 54
11. Sih R. Morley .IE. Kaiser FE et al (1997) Testosterone replacement in older hypogonadal men: a 12-month randomised controlled trial. J Clin F.ntlocrinol Metuh 82: 1661-7
12. Singer PA. Tasch ES, Stocking C et al (1991) Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol 9: 32X-34
13. Townsend ME. Sanders WH. Northway RO. Graham SD Jr (1997) Bone fractures associated with luteiniing hormone-releasing hormone agonists used in the treatment of prostate carcinoma. Cancer 79: 545-50
14. Tyrrell CM. Kaisary AV Kerscn P et al (199X) A randomised comparison of Tasodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metaslatic and locally advanced prostate cancer. Kur nil 33: 447-56
15. Tyrrell CM (1999) (iynaecomastia: aetiology and treatment options. Pntsi Cancer I'nist Dis 2: 167-71